The PAtients pResenTing With COngenital HeaRt DIseAse Register (ARTORIA-R)
Advances in surgical and medical care have led to improved outcomes in patients with congenital heart disease (CHD). As a consequence, the majority of patients nowadays survives to adulthood (adults with CHD, that is, adult CHD \[ACHD\]) with good quality of life. Despite the surgical success, the morbidity and mortali
| Condition(s) | Congenital Heart Disease, Heart Failure, Transplant; Complication, Failure, Arrythmia, Ventricular Dysfunction |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | Advances in surgical and medical care have led to improved outcomes in patients with congenital heart disease (CHD). As a consequence, the majority of patients nowadays survives to adulthood (adults with CHD, that is, adult CHD \[ACHD\]) with good quality of life. Despite the surgical success, the morbidity and mortality of ACHD is higher than in the general population and is linked to the development of heart failure (HF) in adulthood. HF occurs in approximately 25% of patients with ACHD, even in those patients in whom the congenital mal-formation has been corrected successfully in childhood. The time course and presentation are heterogeneous owing to variable congenital malformation and limitation of treatment options. ACHD with an anatomic right ventricle as the systemic ventricle (e.g. |
| Who can participate | Inclusion Criteria: 1. The patient has to be listed as an adult transplant candidate in the country the data is obtained with an age ≥18 years 2. The patient has to have a congenital heart defect or an inherited cardiomyopathy (specific; hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy or non-compaction cardiomyopathy) which is often included into the category ACHD 3. Data is obtained from the first evaluation for listing or listing for heart-only or heart-combined organ transplantation 4. Transfer of anonymised data 5. The institution/organization agrees to the memorandum how data is managed, and scientific cooperation is planned between all institutions Exclusion Criteria: a. The patient is listed for a second heart transplantation (retransplantation) |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Universitätsklinikum Hamburg-Eppendorf |
| Locations | Hamburg, Germany |
| Start date | 2020-09-02 |
| NCT ID | NCT04848844 |
| Official listing | https://clinicaltrials.gov/study/NCT04848844 |